Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purkinje Cells | 35 | 2025 | 86 | 10.100 |
Why?
|
| Cerebellum | 30 | 2025 | 253 | 8.070 |
Why?
|
| Neuronal Plasticity | 24 | 2024 | 205 | 6.650 |
Why?
|
| Synapses | 23 | 2024 | 291 | 5.060 |
Why?
|
| Learning | 11 | 2024 | 305 | 4.130 |
Why?
|
| Long-Term Potentiation | 15 | 2024 | 51 | 3.830 |
Why?
|
| Dendrites | 7 | 2025 | 104 | 3.040 |
Why?
|
| Long-Term Synaptic Depression | 10 | 2018 | 12 | 2.840 |
Why?
|
| Action Potentials | 13 | 2022 | 629 | 2.100 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 6 | 2020 | 15 | 1.980 |
Why?
|
| Calcium | 11 | 2024 | 1205 | 1.710 |
Why?
|
| Animals | 48 | 2025 | 28901 | 1.120 |
Why?
|
| Neurons | 7 | 2023 | 1654 | 1.120 |
Why?
|
| Autism Spectrum Disorder | 3 | 2020 | 87 | 1.110 |
Why?
|
| Axons | 5 | 2024 | 189 | 1.080 |
Why?
|
| Nerve Fibers | 6 | 2019 | 48 | 1.010 |
Why?
|
| Pyramidal Cells | 3 | 2022 | 89 | 0.990 |
Why?
|
| Synaptic Transmission | 6 | 2017 | 233 | 0.930 |
Why?
|
| Motor Activity | 2 | 2020 | 332 | 0.900 |
Why?
|
| Mice | 25 | 2025 | 12525 | 0.890 |
Why?
|
| Patch-Clamp Techniques | 13 | 2016 | 402 | 0.800 |
Why?
|
| Synaptic Potentials | 1 | 2021 | 17 | 0.690 |
Why?
|
| Receptors, AMPA | 4 | 2014 | 68 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 3483 | 0.690 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2012 | 90 | 0.680 |
Why?
|
| Autistic Disorder | 3 | 2020 | 150 | 0.660 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2014 | 1267 | 0.620 |
Why?
|
| Blinking | 2 | 2020 | 17 | 0.600 |
Why?
|
| Brain | 3 | 2024 | 2479 | 0.590 |
Why?
|
| Rats | 15 | 2019 | 4155 | 0.570 |
Why?
|
| Calcium Signaling | 4 | 2019 | 142 | 0.570 |
Why?
|
| Ethanol | 2 | 2012 | 273 | 0.560 |
Why?
|
| Memory | 1 | 2020 | 229 | 0.540 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 168 | 0.530 |
Why?
|
| Mice, Knockout | 8 | 2023 | 2160 | 0.530 |
Why?
|
| Electric Fish | 2 | 2007 | 19 | 0.510 |
Why?
|
| Electric Stimulation | 6 | 2024 | 398 | 0.510 |
Why?
|
| Dioxoles | 1 | 2014 | 8 | 0.440 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2014 | 6 | 0.440 |
Why?
|
| Ataxia | 2 | 2015 | 47 | 0.430 |
Why?
|
| Nerve Net | 4 | 2020 | 407 | 0.420 |
Why?
|
| Cerebellar Cortex | 3 | 2015 | 15 | 0.420 |
Why?
|
| Neural Pathways | 2 | 2006 | 333 | 0.410 |
Why?
|
| Calcium Channels | 3 | 2019 | 183 | 0.400 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 192 | 0.400 |
Why?
|
| Piperidines | 1 | 2014 | 171 | 0.400 |
Why?
|
| Receptors, Muscarinic | 1 | 2013 | 48 | 0.400 |
Why?
|
| Cannabinoids | 1 | 2013 | 16 | 0.390 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2014 | 90 | 0.320 |
Why?
|
| Olivary Nucleus | 1 | 2009 | 7 | 0.300 |
Why?
|
| Periodicity | 1 | 2009 | 119 | 0.280 |
Why?
|
| Biological Clocks | 1 | 2009 | 81 | 0.280 |
Why?
|
| Central Nervous System Depressants | 1 | 2008 | 45 | 0.280 |
Why?
|
| Calcineurin | 2 | 2009 | 19 | 0.260 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2006 | 3 | 0.250 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 85 | 0.250 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 42 | 0.240 |
Why?
|
| Endocannabinoids | 1 | 2006 | 27 | 0.240 |
Why?
|
| Cell Communication | 2 | 2022 | 220 | 0.240 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 58 | 0.230 |
Why?
|
| Sodium Channels | 1 | 2006 | 131 | 0.230 |
Why?
|
| Electrophysiology | 4 | 2014 | 408 | 0.230 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2019 | 88 | 0.230 |
Why?
|
| Humans | 17 | 2025 | 95992 | 0.220 |
Why?
|
| Egtazic Acid | 1 | 2004 | 33 | 0.220 |
Why?
|
| Reflex, Vestibulo-Ocular | 2 | 2020 | 55 | 0.220 |
Why?
|
| Apamin | 2 | 2016 | 4 | 0.220 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 2534 | 0.200 |
Why?
|
| In Vitro Techniques | 5 | 2009 | 1014 | 0.200 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2012 | 82 | 0.190 |
Why?
|
| Perception | 1 | 2024 | 185 | 0.190 |
Why?
|
| Language | 1 | 2024 | 162 | 0.190 |
Why?
|
| Neuronal Calcium-Sensor Proteins | 1 | 2022 | 3 | 0.180 |
Why?
|
| Intellectual Disability | 1 | 2023 | 203 | 0.180 |
Why?
|
| Membrane Potentials | 2 | 2017 | 442 | 0.180 |
Why?
|
| Alternative Splicing | 1 | 2023 | 220 | 0.170 |
Why?
|
| Male | 7 | 2025 | 45792 | 0.170 |
Why?
|
| Ion Channels | 1 | 2002 | 260 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2013 | 3581 | 0.160 |
Why?
|
| Cholinergic Agents | 1 | 2020 | 17 | 0.160 |
Why?
|
| Conditioning, Classical | 1 | 2020 | 38 | 0.160 |
Why?
|
| Hippocampus | 2 | 2017 | 459 | 0.150 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 53 | 0.150 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 18 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 1642 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2019 | 1729 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2009 | 24 | 0.140 |
Why?
|
| Female | 6 | 2025 | 49980 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 232 | 0.120 |
Why?
|
| Potassium Channel Blockers | 1 | 2016 | 67 | 0.120 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2015 | 18 | 0.120 |
Why?
|
| Dendritic Spines | 2 | 2015 | 16 | 0.110 |
Why?
|
| Association Learning | 1 | 2015 | 38 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2015 | 84 | 0.110 |
Why?
|
| Quinoxalines | 2 | 2012 | 51 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 677 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 81 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 1827 | 0.110 |
Why?
|
| Morphogenesis | 1 | 2015 | 211 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 655 | 0.100 |
Why?
|
| Oxotremorine | 1 | 2013 | 4 | 0.100 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 23 | 0.100 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 615 | 0.100 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2012 | 11 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 286 | 0.100 |
Why?
|
| Time Factors | 3 | 2008 | 5593 | 0.100 |
Why?
|
| Muscarinic Antagonists | 1 | 2013 | 61 | 0.100 |
Why?
|
| Cell Compartmentation | 1 | 2012 | 70 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 61 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 176 | 0.090 |
Why?
|
| Calcium Channels, P-Type | 1 | 2010 | 10 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2010 | 435 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2012 | 128 | 0.080 |
Why?
|
| GABA Antagonists | 1 | 2008 | 26 | 0.070 |
Why?
|
| Pyridazines | 1 | 2008 | 22 | 0.070 |
Why?
|
| Biophysics | 1 | 2008 | 157 | 0.070 |
Why?
|
| Aged | 1 | 2025 | 20927 | 0.060 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2007 | 50 | 0.060 |
Why?
|
| Benzylamines | 1 | 2006 | 17 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 488 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 31 | 0.060 |
Why?
|
| Calcineurin Inhibitors | 1 | 2005 | 53 | 0.060 |
Why?
|
| Middle Aged | 1 | 2025 | 28299 | 0.060 |
Why?
|
| Adult | 1 | 2025 | 28636 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2006 | 202 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2004 | 68 | 0.050 |
Why?
|
| Movement | 1 | 2006 | 324 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2006 | 337 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 439 | 0.050 |
Why?
|
| Baclofen | 1 | 2003 | 16 | 0.050 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2023 | 9 | 0.050 |
Why?
|
| Benzophenanthridines | 1 | 2003 | 22 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2003 | 24 | 0.050 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2023 | 12 | 0.050 |
Why?
|
| Alkaloids | 1 | 2003 | 47 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 21 | 0.050 |
Why?
|
| Cerebral Palsy | 1 | 2003 | 96 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 611 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2002 | 159 | 0.040 |
Why?
|
| Genotype | 1 | 2006 | 1883 | 0.040 |
Why?
|
| Cell Death | 2 | 2013 | 264 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2928 | 0.040 |
Why?
|
| Seizures | 1 | 2003 | 331 | 0.040 |
Why?
|
| Behavior Rating Scale | 1 | 2020 | 6 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2023 | 740 | 0.040 |
Why?
|
| Transcription Initiation Site | 1 | 2019 | 47 | 0.040 |
Why?
|
| Internal Ribosome Entry Sites | 1 | 2019 | 16 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2019 | 111 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1966 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 522 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 706 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 382 | 0.030 |
Why?
|
| Conditioning, Eyelid | 1 | 2015 | 3 | 0.030 |
Why?
|
| Neurites | 1 | 2013 | 36 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2010 | 11 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 535 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 112 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 311 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 671 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1191 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2575 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 242 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2007 | 18 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2007 | 43 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 67 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2776 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2007 | 62 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2059 | 0.010 |
Why?
|
| Time | 1 | 2002 | 79 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 686 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 2002 | 108 | 0.010 |
Why?
|
| Temperature | 1 | 2002 | 432 | 0.010 |
Why?
|
| Child | 1 | 2003 | 7621 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 10307 | 0.000 |
Why?
|